These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3625264)

  • 1. Hypersensitivity reactions to teniposide in children.
    Carstensen H; Nolte H; Hertz H; Jensen T
    J Clin Oncol; 1987 Sep; 5(9):1491-2. PubMed ID: 3625264
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic reactions to teniposide in patients with neuroblastoma and lymphoid malignancies.
    Hayes FA; Abromowitch M; Green AA
    Cancer Treat Rep; 1985 Apr; 69(4):439-41. PubMed ID: 3857970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypersensitivity to VM-26].
    Köster B; Ritter J; Bode U
    Klin Padiatr; 1984; 196(3):178-80. PubMed ID: 6540829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity reactions to teniposide (VM-26): an analysis.
    O'Dwyer PJ; King SA; Fortner CL; Leyland-Jones B
    J Clin Oncol; 1986 Aug; 4(8):1262-9. PubMed ID: 3525769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VM-26 (teniposide)-induced hypersensitivity and degranulation of basophils in children.
    Nolte H; Carstensen H; Hertz H
    Am J Pediatr Hematol Oncol; 1988; 10(4):308-12. PubMed ID: 2467573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hypertensive reactions to teniposide (VM-26) in infants with congenital leukemia.
    Shimizu H; Frankel LS; Culbert SJ
    Am J Pediatr Hematol Oncol; 1987; 9(3):239-41. PubMed ID: 3479027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Allergic reactions to teniposide (VM-26) in children with neoplasms].
    Wysocki M; Nowaczyk-Michalak A; Pilecki O
    Wiad Lek; 1992 Feb; 45(3-4):91-3. PubMed ID: 1413803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teniposide-induced hypersensitivity reactions in children.
    Carstensen H; Nolte H; Hertz H
    Lancet; 1989 Jul; 2(8653):55. PubMed ID: 2567836
    [No Abstract]   [Full Text] [Related]  

  • 9. Anaphylactic reactions to teniposide.
    Siddall SJ; Martin J; Nunn AJ
    Lancet; 1989 Feb; 1(8634):394. PubMed ID: 2563558
    [No Abstract]   [Full Text] [Related]  

  • 10. VM-26 as a second drug in the treatment of brain gliomas.
    Kessinger A; Lemon HM; Foley JF
    Cancer Treat Rep; 1979 Mar; 63(3):511-2. PubMed ID: 427830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teniposide is not effective in chronic lymphocytic leukemia.
    Zagonel V; Tirelli U; Veronesi A; Galligioni E; Tumolo S; Roncadin M; Carbone A; Grigoletto E
    Blut; 1986 Jan; 52(1):59-61. PubMed ID: 3632912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epipodophyllotoxin VM-26 in the treatment of childhood neuroblastoma.
    Rivera G; Green A; Hayes A; Avery T; Pratt C
    Cancer Treat Rep; 1977 Oct; 61(7):1243-8. PubMed ID: 589594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
    Locker GY; Lanzotti V; Khandekar JD; Sweet D; Shaw J; Bitran J; Gordon L; Krauss S; Johnson C
    Cancer Treat Rep; 1986 Feb; 70(2):307-8. PubMed ID: 3948195
    [No Abstract]   [Full Text] [Related]  

  • 14. Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.
    Oishi N; Berenberg J; Blumenstein BA; Johnson K; Rivkin SE; Bukowski RM; O'Bryan RM; Stephens RL; Quagliana J; Saiers JH
    Cancer Treat Rep; 1987 Dec; 71(12):1307-8. PubMed ID: 3690547
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II trial of VM-26 in patients with metastatic malignant melanoma.
    Bellet RE; Catalno RB; Mastrangelo MJ; Berd D; Koons LS
    Cancer Treat Rep; 1978 Mar; 62(3):445-7. PubMed ID: 348313
    [No Abstract]   [Full Text] [Related]  

  • 16. Teniposide in epithelial ovarian carcinoma: a phase II trial of the Gynecologic Oncology Group.
    Muss H; Bundy BN; DiSaia PJ; Twiggs LB
    Cancer Treat Rep; 1986 Oct; 70(10):1231-2. PubMed ID: 3530450
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonresponsiveness of brain tumors to VM-26 therapy in children.
    Sullivan MP; van Eys J; Herson J; Starling KA; Ragab A; Sexhauer C
    Cancer Treat Rep; 1979 Jan; 63(1):155-6. PubMed ID: 369689
    [No Abstract]   [Full Text] [Related]  

  • 18. Teniposide in the treatment of non-small cell lung carcinoma.
    Giaccone G; Donadio M; Ferrati P; Bonardi G; Ciuffreda L; Bagatella M; Calciati A
    Cancer Treat Rep; 1987 Jan; 71(1):83-5. PubMed ID: 3024829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VM26: phase I and II studies.
    Macbeth FR
    Cancer Chemother Pharmacol; 1982; 7(2-3):87-91. PubMed ID: 7044595
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful induction with chemotherapy including teniposide in familial erythrophagocytic lymphohistiocytosis.
    Henter JI; Elinder G; Finkel Y; Söder O
    Lancet; 1986 Dec; 2(8520):1402. PubMed ID: 2878264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.